$DVAX
Market Cap:
$DVAX SEC Filings
| Filing | Filed On |
|---|---|
| 4 | 17 Oct 2012 |
| SC 13D/A | 17 Oct 2012 |
| COFFMAN 10B5-1 SALE | 09 Oct 2012 |
| STEPHEN TUCK PERFORMANCE AWARD RSU | 04 Oct 2012 |
| LEW OPTION EXERCISE | 14 Sep 2012 |
| COFFMAN 10B5-1 SALE | 14 Sep 2012 |
| COFFMAN 10B5-1 SALE | 06 Sep 2012 |
| DYNAVAX ANNOUNCES FDA ADVISORY COMMITTEE TO REVIEW HEPLISAV | 28 Aug 2012 |
| MAA ACCEPTANCE | 23 Aug 2012 |
| CHRISTINE R. LARSON APPOINTED AS CFO | 15 Aug 2012 |
| CT ORDER | 14 Aug 2012 |
| ISSANCE OF STOCK OPTIONS | 14 Aug 2012 |
| LARSON INITIAL HOLDINGS | 14 Aug 2012 |
| FORM 10-Q | 03 Aug 2012 |
| DYNAVAX REPORTS SECOND QUARTER 2012 FINANCIAL RESULTS | 01 Aug 2012 |
| DYNAVAX SUBMITS HEPLISAV(TM) FOR EU MARKETING AUTHORIZATION | 24 Jul 2012 |
| 8-K | 26 Jun 2012 |
| FORM 4 | 21 Jun 2012 |
| 8-K | 01 Jun 2012 |
| FORM 4 | 31 May 2012 |
